6 June 2002
Mediwatch plc ('Mediwatch' or 'the Company')
Ordinary Shares of 10 pence each.
Placing of new Ordinary Shares.
It was announced on 16 May 2002 that Mediwatch, the urology diagnostics company,
conditionally placed 2,275,000 shares with an existing VCT shareholder. This
placing was conditional on the receipt of advance provisional assurance from the
Inland Revenue that the shares could constitute a qualifying holding under the
This assurance has now been received, and the Company announces that Singer &
Friedlander AIM 3 VCT has acquired 2,275,000 shares at a price of 13 pence per
share. Including the above holding, Singer & Friedlander now hold 3,775,000
shares representing 14.0% of the Company.
The funds will be used to provide working capital for the Company and to enable
the Company to continue its programme of product development.
Mediwatch Plc Binns & Co PR Ltd
Phil Stimpson, Chief Executive Officer Peter Binns/Paul McManus
Brian Thomas, Finance Director Tel: 020 7786 9600
Tel: 01788 547 888
This information is provided by RNS
The company news service from the London Stock Exchange